To ensure that you never miss an issue, please whitelist us.
http://www.diabetesincontrol.com/
Getting Patients on Track with GLP-1
June 17, 2012 (Recommend Us)
Homerun Slides: Clinical presentation library
Incretins, Part 1 of 7
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 1 of 4
How It Works
GLP-1 Analogs and DeFronzo's Octet
Items for the Week
AACE: Liraglutide Shows Postive Results in Head To Head Study
One Year Study Showed a 36% Loss in Excess Body Weight
GLP-1 a Good Choice for Glycemic Control?
Feature
An Educator's Perspective: Janet Carson, R.N., C.D.E., Largo, FL
An Endocrinologist's Perspective: Dr. Falal Taris, MD, Diabetes, Metabolism & Endocrinology, Internal Medicine
A Primary Care Physician's Perspective: Dr. Norris Brown, Austin, TX
GLP-1 Agonists: Increasing Effective Insulin Release
GLP-1 and Appetite Suppression
Editor's Note

Most clinicians I work with or have chatted with want to get their patients in optimal control of their glucose levels. We all work hard to find that right combination of medication, food choices, and physical activity that will achieve our patients' goals. This means that we ask patients to make changes that they are not always willing to do, and more importantly not willing to continue long term.

This lack of consistency is often seen with medication adherence as many patients quit taking some or all of their medications for various reasons. Because of this we as clinicians are often swayed in our medication selections as we realize that even the best medications have no chance of working if our patients won't take them.

Last month we talked about Getting Your Patients on Track with GLP-1 Analogs and shared some tips from clinicians who have had great experiences with using them.

This month we have spoken to some of our clinician readers and asked them to share how they keep their patients on track once they have started on GLP-1 analog therapy.


Your partner in diabetes care,

Dave Joffe
Editor-in-chief
Homerun Slides: Clinical presentation library
Incretins, Part 1 of 7

This first of seven sets of Homerun Slides begins with GLP-1 physiology, then examines the actions of DPP-4 inhiitors and GLP-1R agonists, plus....

Click here for Incretins, Part 1 of 7
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 1 of 4

Topics covered include the clinical effects of GLP-1 agonists and DPP-4 inhibitors stemming from incretin action, and the role of glucagon in glucose intolerance and effects of GLP-1 based drugs on plasma glucagon....

Click here for GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 1 of 4
How It Works
GLP-1 Analogs and DeFronzo's Octet

For nearly 2 decades now, GLP-1 has been heavily investigated as the most promising therapy target in type 2 diabetes patients....

Click here for GLP-1 Analogs and DeFronzo's Octet
Items for the Week
AACE: Liraglutide Shows Postive Results in Head To Head Study

Patients more likely to reach A1c target at any given time during 26 weeks' treatment with liraglutide compared with both sitagliptin and exenatide....

Click here for AACE: Liraglutide Shows Postive Results in Head To Head Study
One Year Study Showed a 36% Loss in Excess Body Weight

Obese individuals completed a 1-year study and lost a mean 35.6% of excess body weight taking….

Click here for One Year Study Showed a 36% Loss in Excess Body Weight
GLP-1 a Good Choice for Glycemic Control?

The top three drugs for the reduction of A1c levels are biphasic insulin, glucagon-like peptide 1 (GLP-1) analogs, and….

Click here for GLP-1 a Good Choice for Glycemic Control?
Feature
An Educator's Perspective: Janet Carson, R.N., C.D.E., Largo, FL

Often times there can be difficulty getting approval for the patient to use a GLP-1 analog and so the patient may miss a few days of the medication and possibly decide they don't want to continue. I have gotten in the habit of ordering the medication from the pharmacy the same day that I give them their first month sample. This way the pharmacy can make sure they get the prescription ready before the patient actually needs it and if a prior authorization is needed I can make sure there is plenty of time for the process to occur....

Click here for An Educator's Perspective: Janet Carson, R.N., C.D.E., Largo, FL
An Endocrinologist's Perspective: Dr. Falal Taris, MD, Diabetes, Metabolism & Endocrinology, Internal Medicine

I have been using GLP-1 analogs with my patients for the past five years and have seen many patients find reasons to stop using the medication. They complain about nausea, they complain about the cost, they say the needle hurts and they have even told me that they can't get their money's worth on a cruise because they are unable to eat enough....

Click here for An Endocrinologist's Perspective: Dr. Falal Taris, MD, Diabetes, Metabolism & Endocrinology, Internal Medicine
A Primary Care Physician's Perspective: Dr. Norris Brown, Austin, TX

When the GLP-1 analogs first came out I was slow to start using them. As a primary care physician in a busy multi-practitioner office I was used to working with oral medications for diabetes, and only as a last resort would I put patients on basal insulin. If my patients needed to have more intense glucose management I would refer them to an endocrinologist in our building. Over the years I watched as my practice colleagues used more of the GLP-1 analogs and so I started using them based on the results that my partners were having.....
Click here for A Primary Care Physician's Perspective: Dr. Norris Brown, Austin, TX
GLP-1 Agonists: Increasing Effective Insulin Release

The pathophysiology of type 2 diabetes mellitus is complex, consisting of far more physiologic defects than simple insulin resistance and beta-cell dysfunction....

Click here for GLP-1 Agonists: Increasing Effective Insulin Release
GLP-1 and Appetite Suppression

There has been an increased use of GLP-1 analogs in patients with diabetes over the past two years as the advent of daily dosing has made medication adherence simpler and more clinicians are comfortable with the available choices.

Click here for GLP-1 and Appetite Suppression
Diabetes In Control has over 11000 studies & articles in our archives.
This newsletter is not associated with the American Diabetes Association
Thank you to
Our Advertisers
articles articles articles articles
Copyright 1999-2012 Diabetes In Control
Deerfield, Illinois 60015
To ensure that you never miss an issue, please whitelist us.